DrugCite
Search

REQUIP

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Requip Adverse Events Reported to the FDA Over Time

How are Requip adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Requip, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Requip is flagged as the suspect drug causing the adverse event.

Most Common Requip Adverse Events Reported to the FDA

What are the most common Requip adverse events reported to the FDA?

Drug Ineffective
972 (4.53%)
Nausea
639 (2.98%)
Somnolence
589 (2.75%)
Insomnia
462 (2.16%)
Hallucination
365 (1.7%)
Dizziness
354 (1.65%)
Restless Legs Syndrome
350 (1.63%)
Fatigue
280 (1.31%)
Pathological Gambling
265 (1.24%)
Vomiting
257 (1.2%)
Tremor
256 (1.19%)
Show More Show More
Dyskinesia
236 (1.1%)
Sudden Onset Of Sleep
236 (1.1%)
Oedema Peripheral
202 (.94%)
Confusional State
196 (.91%)
Headache
192 (.9%)
Fall
191 (.89%)
Malaise
183 (.85%)
Gambling
178 (.83%)
Obsessive-compulsive Disorder
169 (.79%)
Feeling Abnormal
151 (.7%)
Asthenia
146 (.68%)
Loss Of Consciousness
146 (.68%)
Muscle Spasms
146 (.68%)
Depression
139 (.65%)
Dyspnoea
134 (.63%)
Pain In Extremity
133 (.62%)
Syncope
132 (.62%)
Abnormal Behaviour
128 (.6%)
Hyperhidrosis
128 (.6%)
Drug Interaction
126 (.59%)
Anxiety
120 (.56%)
Pain
114 (.53%)
Condition Aggravated
113 (.53%)
Death
109 (.51%)
Medication Error
107 (.5%)
Agitation
104 (.49%)
Sleep Disorder
104 (.49%)
Aggression
102 (.48%)
Ill-defined Disorder
102 (.48%)
Hallucination, Visual
101 (.47%)
Gait Disturbance
99 (.46%)
Hypersexuality
94 (.44%)
Product Quality Issue
94 (.44%)
Adverse Event
92 (.43%)
Psychotic Disorder
87 (.41%)
Weight Increased
86 (.4%)
Overdose
85 (.4%)
Restlessness
85 (.4%)
Drug Administration Error
84 (.39%)
Libido Increased
83 (.39%)
Drug Effect Decreased
81 (.38%)
Therapeutic Response Decreased
80 (.37%)
Hypoaesthesia
79 (.37%)
Palpitations
78 (.36%)
Diarrhoea
76 (.35%)
Balance Disorder
73 (.34%)
Arthralgia
70 (.33%)
Road Traffic Accident
68 (.32%)
Hypotension
67 (.31%)
Musculoskeletal Stiffness
67 (.31%)
Suicide Attempt
67 (.31%)
Constipation
66 (.31%)
Rash
66 (.31%)
Movement Disorder
65 (.3%)
Delirium
64 (.3%)
Paraesthesia
64 (.3%)
Weight Decreased
64 (.3%)
Chest Pain
63 (.29%)
Suicidal Ideation
62 (.29%)
Pyrexia
61 (.28%)
Amnesia
60 (.28%)
Abdominal Pain Upper
59 (.28%)
Delusion
58 (.27%)
Paranoia
58 (.27%)
Myalgia
57 (.27%)
Wrong Drug Administered
57 (.27%)
Pneumonia
56 (.26%)
Therapeutic Response Unexpected
56 (.26%)
Abnormal Dreams
54 (.25%)
Middle Insomnia
54 (.25%)
Nightmare
53 (.25%)
Withdrawal Syndrome
53 (.25%)
Cough
52 (.24%)
Medication Residue
49 (.23%)
Back Pain
48 (.22%)
Convulsion
48 (.22%)
Dysphagia
48 (.22%)
Mania
48 (.22%)
Impulse-control Disorder
47 (.22%)
Parkinsonism
47 (.22%)
Mobility Decreased
46 (.21%)
Disorientation
45 (.21%)
Dry Mouth
45 (.21%)
Fear
45 (.21%)
Heart Rate Increased
45 (.21%)
Joint Swelling
45 (.21%)
Muscular Weakness
44 (.21%)
Inappropriate Schedule Of Drug Admi...
43 (.2%)
Thinking Abnormal
43 (.2%)
Drug Dispensing Error
42 (.2%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Requip, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Requip is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Requip

What are the most common Requip adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Requip, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Requip is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Requip According to Those Reporting Adverse Events

Why are people taking Requip, according to those reporting adverse events to the FDA?

Restless Legs Syndrome
3774
Parkinsons Disease
2618
Drug Use For Unknown Indication
865
Product Used For Unknown Indication
346
Parkinsonism
105
Muscle Spasms
55
Show More Show More
Periodic Limb Movement Disorder
33
Ill-defined Disorder
25
Sleep Disorder
22
Tremor
22
Neuropathy Peripheral
13
Dyskinesia
9
Limb Discomfort
8
Depression
8
Poor Quality Sleep
7
Pain In Extremity
7
Fibromyalgia
6
Musculoskeletal Disorder
6
Movement Disorder
6
Restlessness
5
Dementia
5
Myoclonus
5
Nerve Injury
5
Drug Effect Decreased
5
Pain
5
Insomnia
4
Neuralgia
4
Diabetic Nephropathy
4
Multiple Sclerosis
4
Dementia With Lewy Bodies
3
Sleep Apnoea Syndrome
3
Muscle Twitching
3
Accidental Exposure
3
Medication Error
3
Muscle Spasticity
3
Akinesia
3
Gait Disturbance
3
Muscle Disorder
2
Sexual Dysfunction
2
Pollakiuria
2
Back Disorder
2
Dystonia
2
Apathy
2
Bipolar Disorder
2
Hypothyroidism
2
Musculoskeletal Stiffness
2
Arthritis
2
Neuropathy
2
Mental Disorder
2
Parkinsonian Rest Tremor
2
Huntingtons Chorea
1

Drug Labels

LabelLabelerEffective
Requip PD-Rx Pharmaceuticals, Inc.25-AUG-11
RequipxlPhysicians Total Care, Inc.27-DEC-11
RequipGlaxoSmithKline LLC11-JUL-12
RequipxlGlaxoSmithKline LLC18-DEC-12
RequipBryant Ranch Prepack18-JAN-13

Requip Case Reports

What Requip safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Requip. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Requip.